Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program

Detalhes bibliográficos
Autor(a) principal: Araújo,Tiago de Assis Clemente de
Data de Publicação: 2020
Outros Autores: Medeiros,Daniel Machado, Paiva,Isabel Braga, Andrade,Camila Galvão de, Rocha,Camilla da Silva, Britto,Danielle Cândido, Santos,Michel Bittencourt
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Brasileira de Oftalmologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000400258
Resumo: Abstract Objective: To evaluate the adherence to clinical glaucoma treatment in patients that benefit from the Brazilian National Glaucoma Program and receive antiglaucomatous eye drops free of charge. Methods: This cross-sectional study included 255 patients that benefit from the Brazilian National Glaucoma Program (BNGP) and were assisted at the Altino Ventura Foundation (FAV), Pernambuco state, Brazil. The Morisky’s Adhesion Scale (MAS) was used to evaluate adhesion profile to treatment. Patients with a Morisky’s Adhesion score ≥ 6 was considered adherent to treatment. The analyzed variables included sex, educational level, distance from home to the treatment center, number of eye drops used, time since the glaucoma diagnosis, patients’ subjective classification of their quality of vision, and prevalence of other comorbidities. Results: A total of 255 patients [167 (65.4%) females] were included in this study with a mean age was 65.9 ± 13.8 years (range, 11-99 years). Adherence to clinical glaucoma treatment was seen in 155 patients (60.8%). Worse adherence to treatment was observed in female patients (p=0.034), with low education level (p=0.046), who presented other comorbidities (p=0.048), living in remote areas (p=0.038), judged their vision as satisfactory (p=0.046), and who were recently diagnosed with glaucoma (p=0.001). Conclusion: 40% of patients who benefited from the Brazilian National Glaucoma Program were not compliant to treatment. Low adhesion rate was mostly seen in female patients, socially vulnerable, living in remote areas, recently diagnosed with glaucoma, using fewer eyedrops, presenting other comorbidities, and in those that considering themselves of having a satisfactory vision.
id SBO-1_ba679d9d3735ef88cfcc7aedd114032d
oai_identifier_str oai:scielo:S0034-72802020000400258
network_acronym_str SBO-1
network_name_str Revista Brasileira de Oftalmologia (Online)
repository_id_str
spelling Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma ProgramIntraocular pressureGlaucomaBlindnessPatient complianceAdherence to treatmentAbstract Objective: To evaluate the adherence to clinical glaucoma treatment in patients that benefit from the Brazilian National Glaucoma Program and receive antiglaucomatous eye drops free of charge. Methods: This cross-sectional study included 255 patients that benefit from the Brazilian National Glaucoma Program (BNGP) and were assisted at the Altino Ventura Foundation (FAV), Pernambuco state, Brazil. The Morisky’s Adhesion Scale (MAS) was used to evaluate adhesion profile to treatment. Patients with a Morisky’s Adhesion score ≥ 6 was considered adherent to treatment. The analyzed variables included sex, educational level, distance from home to the treatment center, number of eye drops used, time since the glaucoma diagnosis, patients’ subjective classification of their quality of vision, and prevalence of other comorbidities. Results: A total of 255 patients [167 (65.4%) females] were included in this study with a mean age was 65.9 ± 13.8 years (range, 11-99 years). Adherence to clinical glaucoma treatment was seen in 155 patients (60.8%). Worse adherence to treatment was observed in female patients (p=0.034), with low education level (p=0.046), who presented other comorbidities (p=0.048), living in remote areas (p=0.038), judged their vision as satisfactory (p=0.046), and who were recently diagnosed with glaucoma (p=0.001). Conclusion: 40% of patients who benefited from the Brazilian National Glaucoma Program were not compliant to treatment. Low adhesion rate was mostly seen in female patients, socially vulnerable, living in remote areas, recently diagnosed with glaucoma, using fewer eyedrops, presenting other comorbidities, and in those that considering themselves of having a satisfactory vision.Sociedade Brasileira de Oftalmologia2020-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000400258Revista Brasileira de Oftalmologia v.79 n.4 2020reponame:Revista Brasileira de Oftalmologia (Online)instname:Sociedade Brasileira de Oftalmologia (SBO)instacron:SBO10.5935/0034-7280.20200055info:eu-repo/semantics/openAccessAraújo,Tiago de Assis Clemente deMedeiros,Daniel MachadoPaiva,Isabel BragaAndrade,Camila Galvão deRocha,Camilla da SilvaBritto,Danielle CândidoSantos,Michel Bittencourteng2021-01-29T00:00:00Zoai:scielo:S0034-72802020000400258Revistahttps://rbo.emnuvens.com.br/rbo/indexhttps://old.scielo.br/oai/scielo-oai.phpsob@sboportal.org.br||rbo@sboportal.org.br1982-85510034-7280opendoar:2021-01-29T00:00Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO)false
dc.title.none.fl_str_mv Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program
title Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program
spellingShingle Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program
Araújo,Tiago de Assis Clemente de
Intraocular pressure
Glaucoma
Blindness
Patient compliance
Adherence to treatment
title_short Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program
title_full Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program
title_fullStr Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program
title_full_unstemmed Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program
title_sort Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program
author Araújo,Tiago de Assis Clemente de
author_facet Araújo,Tiago de Assis Clemente de
Medeiros,Daniel Machado
Paiva,Isabel Braga
Andrade,Camila Galvão de
Rocha,Camilla da Silva
Britto,Danielle Cândido
Santos,Michel Bittencourt
author_role author
author2 Medeiros,Daniel Machado
Paiva,Isabel Braga
Andrade,Camila Galvão de
Rocha,Camilla da Silva
Britto,Danielle Cândido
Santos,Michel Bittencourt
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Araújo,Tiago de Assis Clemente de
Medeiros,Daniel Machado
Paiva,Isabel Braga
Andrade,Camila Galvão de
Rocha,Camilla da Silva
Britto,Danielle Cândido
Santos,Michel Bittencourt
dc.subject.por.fl_str_mv Intraocular pressure
Glaucoma
Blindness
Patient compliance
Adherence to treatment
topic Intraocular pressure
Glaucoma
Blindness
Patient compliance
Adherence to treatment
description Abstract Objective: To evaluate the adherence to clinical glaucoma treatment in patients that benefit from the Brazilian National Glaucoma Program and receive antiglaucomatous eye drops free of charge. Methods: This cross-sectional study included 255 patients that benefit from the Brazilian National Glaucoma Program (BNGP) and were assisted at the Altino Ventura Foundation (FAV), Pernambuco state, Brazil. The Morisky’s Adhesion Scale (MAS) was used to evaluate adhesion profile to treatment. Patients with a Morisky’s Adhesion score ≥ 6 was considered adherent to treatment. The analyzed variables included sex, educational level, distance from home to the treatment center, number of eye drops used, time since the glaucoma diagnosis, patients’ subjective classification of their quality of vision, and prevalence of other comorbidities. Results: A total of 255 patients [167 (65.4%) females] were included in this study with a mean age was 65.9 ± 13.8 years (range, 11-99 years). Adherence to clinical glaucoma treatment was seen in 155 patients (60.8%). Worse adherence to treatment was observed in female patients (p=0.034), with low education level (p=0.046), who presented other comorbidities (p=0.048), living in remote areas (p=0.038), judged their vision as satisfactory (p=0.046), and who were recently diagnosed with glaucoma (p=0.001). Conclusion: 40% of patients who benefited from the Brazilian National Glaucoma Program were not compliant to treatment. Low adhesion rate was mostly seen in female patients, socially vulnerable, living in remote areas, recently diagnosed with glaucoma, using fewer eyedrops, presenting other comorbidities, and in those that considering themselves of having a satisfactory vision.
publishDate 2020
dc.date.none.fl_str_mv 2020-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000400258
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000400258
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/0034-7280.20200055
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Oftalmologia
publisher.none.fl_str_mv Sociedade Brasileira de Oftalmologia
dc.source.none.fl_str_mv Revista Brasileira de Oftalmologia v.79 n.4 2020
reponame:Revista Brasileira de Oftalmologia (Online)
instname:Sociedade Brasileira de Oftalmologia (SBO)
instacron:SBO
instname_str Sociedade Brasileira de Oftalmologia (SBO)
instacron_str SBO
institution SBO
reponame_str Revista Brasileira de Oftalmologia (Online)
collection Revista Brasileira de Oftalmologia (Online)
repository.name.fl_str_mv Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO)
repository.mail.fl_str_mv sob@sboportal.org.br||rbo@sboportal.org.br
_version_ 1752122339095478272